Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Gains from Investment Securities: 2013-2025

Historic Gains from Investment Securities for Phibro Animal Health (PAHC) over the last 13 years, with Sep 2025 value amounting to $3.7 million.

  • Phibro Animal Health's Gains from Investment Securities rose 432.79% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 million, marking a year-over-year increase of 19.25%. This contributed to the annual value of $4.5 million for FY2025, which is negligibly% changed negligibly from last year.
  • Per Phibro Animal Health's latest filing, its Gains from Investment Securities stood at $3.7 million for Q3 2025, which was down 78.48% from $17.2 million recorded in Q2 2025.
  • In the past 5 years, Phibro Animal Health's Gains from Investment Securities ranged from a high of $19.3 million in Q2 2024 and a low of -$3.2 million during Q4 2024.
  • Moreover, its 3-year median value for Gains from Investment Securities was $521,000 (2025), whereas its average is $4.9 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first surged by 2,015.38% in 2021, then plummeted by 410.36% in 2023.
  • Quarterly analysis of 5 years shows Phibro Animal Health's Gains from Investment Securities stood at $1.8 million in 2021, then slumped by 173.16% to -$1.3 million in 2022, then fell by 15.62% to -$1.6 million in 2023, then plummeted by 107.01% to -$3.2 million in 2024, then skyrocketed by 432.79% to $3.7 million in 2025.
  • Its Gains from Investment Securities was $3.7 million in Q3 2025, compared to $17.2 million in Q2 2025 and $521,000 in Q1 2025.